Semi-synthetic heparinoid polysaccharide
Pentosan Polysulfate
Label Approved for one indication
What it is
Pentosan polysulfate sodium is a semi-synthetic sulfated polysaccharide derived from beech wood hemicellulose. It is FDA-approved as Elmiron for interstitial cystitis (bladder pain syndrome). It appears in peptide-adjacent discussion because veterinary and human research has explored injectable forms for joint and cartilage conditions — a use that is not approved.
Benefits in plain language
What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.
- Not a peptide — it is a large sugar-based molecule, in the same broad family as heparin.
- It has a real approval: oral capsules for bladder pain syndrome.
- The joint and cartilage interest comes from veterinary injections, not from the approved human product.
- Long-term oral use carries a documented eye risk that is easy to miss in casual discussion.
If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.
Mechanism of action
As a heparinoid, pentosan polysulfate binds to bladder mucosal surfaces, thought to restore the glycosaminoglycan layer that normally protects urothelium. Systemically it has weak anticoagulant activity and has been studied for anti-inflammatory and cartilage-protective effects in vitro and in animal joint models.
Possible side effects / caveats
The most significant documented concern is pigmentary maculopathy — a retinal change associated with long-term oral use, sometimes irreversible. Other effects include GI upset, hair loss, and mild bleeding risk. Injectable joint use is not approved, and self-administration of a heparinoid carries bleeding and contamination hazards.
Protocol ranges
| Source tier | Amount | Frequency / duration | Notes |
|---|---|---|---|
| Label | 100 mg oral capsule | Three times daily, per prescribing information | Interstitial cystitis only; requires monitoring |
| Cited range | Veterinary intra-articular regimens | Per veterinary protocol | Not an approved human use |